T-DM1 With Abraxane and Lapatinib for Metastatic HER2 Positive Breast Cancer

NCT02073916 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Breast Cancer

Interventions

DRUG: T-DM1
DRUG: Lapatinib
DRUG: Abraxane

Sponsor

Jenny C. Chang, MD

Collaborators

[object Object]